Mylan N.V. (MYL) Misses Q2 EPS by 15c, Guidance Misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Statement from Mylan's Board of Directors
August 8, 2018 8:31 AM EDTHERTFORDSHIRE, England, Aug. 8, 2018 /PRNewswire/ -- Global pharmaceutical company Mylan N.V.'s (NASDAQ: MYL) board of directors today released the following statement:
Over the past decade, Mylan's Board of Directors and management team have turned Mylan into a leading global platform with a highly-diversified portfolio of products across broad therapeutic areas and geographies. Our long-term strategy and management's continued execution have consistently served the best interests of all of our stakeholders.
Our international business, in which we expect continued growth, now represents more than 60% of the company's global... More
Mylan Reports Second Quarter 2018 Results and Updates 2018 Guidance
August 8, 2018 8:31 AM EDTHERTFORDSHIRE, England and PITTSBURGH, Aug. 8, 2018 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced its financial results for the quarter and six months ended June 30, 2018.
Second Quarter 2018 Financial Highlights
Total revenues of $2.81 billion, down 5% compared to the prior year period. Rest of World segment net sales of $764.1 million, up 10%, up 11% on a constant currency basis. Europe segment net sales of $990.6 million, up 4%, down 3% on... More